Total comprehensive income for the period, net of tax
-38 902
-52 715
-170 738
Statements of financial position
(in NOK thousand)
Note
31 March 2026
31 March 2025
31 Des 2025
Assets
Intangible assets
4
84 403
81 880
84 508
Assets under construction
4
2 114 496
738 283
1 781 081
Buildings and property
4
1 504 544
1 520 670
1 516 707
Fixtures an fittings
4
285 302
295 414
289 282
Right-of-use assets
4
44 106
47 610
45 513
Investment in associated companies
4 701
9 522
6 073
Other long-term receivables
13 169
0
13 169
Total non-current assets
4 050 720
2 693 379
3 736 332
Inventory
3
11 731
9 500
11 351
Biological assets
3
172 512
202 350
232 335
Trade receivables
84 322
49 935
10 314
Other current receivables
50 178
53 310
51 585
Financial derivatives
5
18 740
14 069
10 254
Cash and cash equivalents
137 294
417 884
163 438
Total current assets
474 778
747 049
479 276
Total assets
4 525 498
3 440 427
4 215 608
Equity and liabilities
Share capital
8
23 130
23 130
23 130
Share premium
8
2 414 996
2 415 049
2 414 997
Other reserves
13 797
11 838
13 310
Uncovered losses
-427 666
-279 117
-388 765
Total equity
2 024 257
2 170 900
2 062 673
Long-term interest-bearing debt
9
17 300
818 800
1 545 228
Lease liabilities - long term
9
29 114
32 019
30 088
Other long-term liabilities
9
3 643
3 643
3 643
Total non-current liabilities
50 057
854 462
1 578 959
Short-term interest-bearing debt
9
2 187 697
163 237
334 571
Trade payables
212 919
220 490
192 047
Social security and other taxes
2 841
1 721
7 527
Lease liabilities - short term
9
10 925
12 819
10 987
Other short-term liabilities
36 801
16 798
28 842
Total current liabilities
2 451 184
415 065
573 975
Total liabilities
2 501 241
1 269 528
2 152 934
Total equity and liabilities
4 525 498
3 440 427
4 215 607
Statement of cash flow
(in NOK thousand)
Note
Q1 2026
Q1 2025
2025
Profit/loss before tax
-38 191
-52 407
-170 738
Adjustments for:
Depreciation, amortisation and impairment loss
4
20 727
21 321
84 473
Net financials
26
7 738
28 324
Share based payment expenses
487
355
-1 827
Changes in working capital:
Change in trade receivables
-74 144
40 793
67 598
Change in other current receivables
1 309
-2 838
-3 808
Change in inventory and biological assets
3
32 563
-47 132
-41 438
Change in fair value of biomass
3
26 866
19 256
-15 630
Change in trade payables
7 842
6 800
-4 937
Change in social security and other taxes
-4 733
-1 999
442
Change in other current liabilities
1 375
1 555
-1 511
Cash (outflow) from operations
-25 874
-6 558
-59 052
Cash flow from investment activities
Payments for fixed assets
4
-289 278
-238 012
-1 260 474
Proceeds from government grants
0
0
2 258
Payments for intangible assets
4
-322
-894
-3 960
Financial income received
1 856
1 092
9 746
Net cash (outflow) from investment activities
-287 744
-237 814
-1 252 431
Cash flow from financing activities
Proceeds from new borrowings
9
325 498
254 750
1 153 412
Repayment of borrowings
-300
-300
-1 200
Payments of principal portion of lease liabilities
-2 602
-4 812
-12 173
Interest paid lease liabilities
-663
-411
-2 503
Financial expenses paid
-34 458
-16 432
-92 078
Net cash (outflow) from financing activities
287 474
232 794
1 045 458
Net change in cash and cash equivalents
-26 143
-11 578
-266 024
Cash and cash equ. at the beginning of the period
163 438
429 462
429 462
Cash and cash equ. at the end of the period
137 294
417 884
163 438
Statement of Changes in Equity
(in NOK thousand)
Note
Share capital
Share premium
Other reserves
Other equity
Uncovered losses
Total equity
Balance at 1 January 2025
8
23 130
2 415 049
11 483
0
-226 402
2 223 260
Profit/loss for the period
0
0
0
0
-52 407
-52 407
Other comprehensive income
0
0
0
0
-308
-308
Total comprehensive income
0
0
0
0
-52 715
-52 715
Share based payment expensed
355
355
Transactions with owners
0
0
355
0
0
355
Balance at 31 March 2025
8
23 130
2 415 049
11 838
0
-279 117
2 170 900
Balance at 1 January 2026
8
23 130
2 414 996
13 310
0
-388 764
2 062 673
Profit/loss for the period
0
0
0
0
-38 191
-38 191
Other change
0
0
0
0
0
Other comprehensive income
0
0
0
0
-711
-711
Total comprehensive income
0
0
0
0
-38 902
-38 902
Other paid-in capital
0
0
0
0
0
0
Share based payment expensed
0
0
487
0
0
487
Transactions with owners
0
0
487
0
0
487
Balance at 31 March 2026
8
23 130
2 414 996
13 797
0
-427 666
2 024 257
Selected notes to the quarterly financial statements
Note 1 Summary of significant accounting policies
General information
Salmon Evolution ASA and its subsidiaries, Salmon Evolution Norway AS, Salmon Evolution International AS, Salmon Evolution Dale AS, Salmon Evolution Sales AS and Salmon Evolution Technology AS (the “Company”, "SE" or "the Company") is a Norwegian land-based salmon farmer headquartered in Hustadvika kommune in Møre og Romsdal.
Salmon Evolution operates a hybrid flow-through (HFS) system, utilizing fresh seawater from the Norwegian coast. The Company is building a land-based salmon farming facility at Indre Harøy, with a planned annual production of 36,000 tons HOG fully built. Phase 1, with a planned annual production of 7,900 tons HOG, is fully operational, whilst construction of phase 2 planned to add an addition 10,100 tons HOG bringing total production up to 18,000 tons HOG was initiated in August 2024.
These interim financial statements were approved by the Board of Directors on 5 May 2026.
These interim financial statements have not been audited.
Consolidation
These condensed consolidated statements for the period ended 31 March 2026 include Salmon Evolution ASA together with its subsidiaries Salmon Evolution Norway AS, Salmon Evolution International AS, Salmon Evolution Dale AS, Salmon Evolution Sales AS and Salmon Evolution Technology AS.
Basis of preparation
These interim financial statements have been prepared in accordance with International Accounting Standard 34, "Interim financial reporting". These interim financial statements do not provide the same scope of information as the annual financial statement and should therefore be read in conjunction with the annual financial statements for the year ended 31 December 2025, which have been prepared in accordance with IFRS® Accounting Standards as adopted by the EU.
Going concern
The Company has adopted the going concern basis in preparing its consolidated financial statements. When assessing this assumption, management has assessed all available information about the future. After making such assessments, management has a reasonable expectation that the Company has adequate resources to continue its operational existence for the foreseeable future.
Accounting policies
The accounting policies adopted are consistent with those of the previous financial year except that income tax expense is recognized in each interim period using the expected weighted average annual income tax rate for the full financial year. Taxes on income in the interim periods are accrued using the tax rate that would be applicable to expected total annual profit or loss. The Company does not include net deferred tax benefits in its balance that exceeds the tax effect of group contributions in order to equalize tax payable in its subsidiaries.
Revenue
Revenue from contracts with customers as defined in IFRS 15 is recognised when control of the goods is transferred to the customer at an amount that reflects the consideration to which the group expects to be entitled in exchange for those goods.
Revenue for the Company derives from sale of whole and processed salmon in the spot marked. It has not been made any forward sales contracts. The Company recognised revenue at the point in time when control of the goods is transferred to the customer at an amount that reflects the expected amount that the group is entitled to have for the goods. The sales price is based on available market price where the price will vary with both quality and size.
Normal credit term of the sales transactions is 30 days. If the delivered products have discrepancies compared to the agreed sales contract, cash refunds are given to the customer. Up until now, refunds are not material.
Property, plant & equipment
Property, plant, and equipment is measured at cost, which includes capitalized borrowing costs, less accumulated depreciation and costs include expenditures that are directly attributable to the acquisition and placement of fixed assets in service. Costs of major replacements and renewals that substantially extend the economic life and functionality of fixed asset are capitalized. Costs associated with normal maintenance and repairs are expensed as incurred.
Assets are normally considered property, plant, and equipment if the useful economic life exceeds one year. Straight-line depreciation is applied over the useful life of property, plant, and equipment based on the asset’s historical cost. If a substantial part of an asset has an individual and different useful life, that portion is depreciated separately. The asset’s residual value and useful life are evaluated annually. Gains or losses arising from the disposal or retirement of an asset are determined as the difference between the sales proceeds and the carrying amount of the asset and recognized as part of other income in the accompanying statements of other comprehensive income.
Depreciation is charged to expense when the property, plant or equipment is ready for intended use. For the second phase build out, which expected to be ready for intended use during 2026, assets under construction is not depreciated.
Biological assets
Biological assets are, in accordance with IAS 41, measured at fair value unless the fair value cannot be measured reliably. For salmon in the grow-out facility, a present value model is applied to estimate the fair value. For roe, fry and smolt, historical cost is deemed to provide the best estimate of fair value, and hence applied.
Cost of production is adjusted for unutilized production capacity. The Company has started to take some costs related to the preparation and testing of phase 2.
For further information, please refer to note 3.
Borrowing costs
In accordance with IAS 23, the Company’s loan agreements are subject to the following principles relating to borrowing costs:
General and specific borrowing costs that are attributable to the acquisition, construction or production of a qualifying asset are capitalized during the period of time that is required to complete and prepare the asset for its intended use or sale. Qualifying assets are assets that necessarily take a substantial period of time to get ready for their intended use or sale.
Application of IAS 23 has been taken into consideration where the Group has general borrowings which has partly been financing qualifying assets but not been directly allocated to the construction of a qualifying asset. See note 5 for more information.
Other borrowing costs are expensed in the period in which they are incurred.
Note 2 Segment
The Company has implemented segment reporting which consists of production of farmed salmon in Norway (Farming Norway), other activities (Other), and eliminations. The segment performance is monitored to assess performance and profitability at a strategic level.
Farming Norway consists of Salmon Evolution Norway AS (grow-out facility), Salmon Evolution Dale AS (smolt facility) and Salmon Evolution Sales AS. Additionally a portion of the Group overhead costs is allocated to the segment. Other consist of both revenue and costs not attributable to the farming segment.
Sales revenue from contracts with customers comes from both Europe, UK, Asia, US and other markets.
Q1 2026
(In thousand NOK)
Farming Norway
Other
Eliminations
Group
External revenue
152 239
0
0
152 239
Internal revenue
0
9 584
-9 584
0
Operating revenue
152 239
9 584
-9 584
152 239
Change in inventory
-32 576
0
0
-32 576
Cost of materials
-38 323
0
0
-38 323
Personnel expenses
-14 758
-13 775
9 584
-18 949
Other operating expenses
-48 956
-4 021
14
-52 964
Operational EBITDA
17 625
-8 212
14
9 427
Operational EBIT
-2 608
-9 179
488
-11 300
Fair value adjustment of biomass
-26 866
0
0
-26 866
Net financial
-28 433
27 004
1 403
-26
Profit/loss before tax
-57 907
17 825
1 891
-38 191
Harvested volum (tonnes, HOG)
1 765
1 765
Operational EBITDA/kg (NOK)
10,0
5,3
Operational EBIT/kg (NOK)
-1,5
-6,4
Total PPE
3 997 180
91 023
-55 353
4 032 851
Q1 2025
(In thousand NOK)
Farming Norway
Other
Eliminations
Group
External revenue
59 188
0
-9 520
49 668
Internal revenue
0
8 151
-8 151
0
Operating revenue
59 188
8 151
-17 670
49 668
Change in inventory
38 948
0
8 572
47 520
Cost of materials
-37 868
0
0
-37 868
Personnel expenses
-15 495
-12 726
8 151
-20 071
Other operating expenses
-39 115
-4 733
508
-43 340
Operational EBITDA
5 657
-9 309
-440
-4 092
Operational EBIT
-14 049
-11 399
35
-25 413
0
Fair value adjustment of biomass
-19 256
0
-0
-19 256
Net financial
-38 723
33 144
-2 158
-7 738
Profit/loss before tax
-72 028
21 745
-52 407
Harvested volum (tonnes, HOG)
581
Operational EBITDA/kg (NOK)
9,7
Operational EBIT/kg (NOK)
-24,2
Total PPE
2 651 889
89 216
2 683 857
FY 2025
(In thousand NOK)
Farming Norway
Other
Eliminations
Group
External revenue
325 250
772
0
326 022
Internal revenue
0
33 500
-33 500
0
Operating revenue
325 250
34 272
-33 500
326 022
Change in inventory
43 711
0
0
43 711
Cost of materials
-205 055
0
1 991
-203 064
Personnel expenses
-49 976
-53 044
22 022
-80 998
Other operating expenses
-153 413
-20 431
9 487
-164 357
Operational EBITDA
-39 483
-39 203
0
-78 686
Operational EBIT
-116 399
-44 404
1 896
-158 906
Fair value adjustment of biomass
15 630
Net financial
-28 324
Profit/loss before tax
-171 601
Harvested volum (tonnes, HOG)
4 403
4 403
Operational EBITDA/kg (NOK)
-9,0
-17,9
Operational EBIT/kg (NOK)
-26,4
-36,1
Total assets
3 644 993
33 459
38 636
3 717 088
Note 3 Biological assets and inventory
Biological assets are, in accordance with IAS 41, measured at fair value. For salmon in the grow-out facility, a present value model is applied to estimate the fair value. For roe, fry and smolt, historical cost is deemed to provide the best estimate of fair value, and hence applied.
The fair value of fish in the grow-out facility is calculated by multiplying the estimated biomass at the time of harvest with the estimated sales price at the same time and deducted for estimated costs to sell. For fish not ready for harvest, remaining production costs to grow the fish to harvest weight are deducted. The cash flow is further discounted by a discount rate considering both risk adjustment and time value.
The Company considers that fish greater than 4.6 kg is ready for harvest (about 3.8 kg gutted weight), and such fish is thus classified as harvestable fish. Fish that have not achieved this weight are classified as non-harvestable.
In the event of incident-based mortality, all costs allocated to fish affected by incident-based mortality will be deducted from the book value of the inventory.
Book value of inventory
(in NOK thousand)
Q1 2026
Q1 2025
Equipment
6 720
5 962
Raw materials
5 011
3 538
Biological assets
172 512
202 350
Finished goods
0
0
Total
184 243
211 850
Biological assets
(tonnes)
Q1 2026
Q1 2025
Biological assets end of period
2 334
2 939
Biological assets
(in NOK thousand)
Q1 2026
Q1 2025
FY 2025
Biological assets beginning of period
232 335
171 004
171 004
Increase due to production
97 223
98 059
411 389
Reduction due to harvest/sale
-130 180
-47 457
-365 687
Fair value adjustment beginning of period
-37 021
-21 391
-21 391
Fair value adjustment end of period
10 155
2 135
37 021
Biological assets end of period
172 512
202 350
232 335
The estimated biomass volume is based on the actual number of individuals in the grow-out departments on the balance sheet date, adjusted for projected mortality up to harvest time and multiplied with the estimated harvest weight per individual at harvest time.
The estimated sales price for the fish in the grow-out facility is based on forward prices from Sisalmoni with relevant adjustments. The net sales value is adjusted for expected quality differences and harvesting, logistics and sales expenses.
Note 4 Property, plant, equipment, right of use- and intangible asset
Straight-line depreciation is applied over the useful life of property, plant, and equipment based on the asset’s historical cost and estimated residual value at disposal. Depreciation is charged to expense when the property, plant or equipment is ready for intended use.
(in NOK thousand)
Intangible assets
Assets under construction
Buildings and property
Fixtures and fittings
Right-of-use assets
Total
Cost 1 January 2025
81 136
481 778
1 598 739
342 102
33 184
2 536 939
Additions
2 144
256 505
277
9 630
31 600
300 157
Cost 31 March 2025
83 279
738 283
1 599 016
351 733
64 785
2 837 096
Acc. depreciation 1 January 2025
-34
0
-68 077
-48 480
-15 328
-131 919
Depreciation for the period
-1 365
0
-10 270
-7 839
-1 847
-21 321
Net book value 31 March 2025
81 880
738 283
1 520 670
295 414
47 610
2 683 857
(in NOK thousand)
Intangible assets
Assets under construction
Buildings and property
Fixtures and fittings
Right-of-use assets
Total
Cost 1 January 2026
86 346
1 781 080
1 625 586
361 493
70 471
3 924 976
Additions
322
333 415
-1 596
3 084
1 264
336 489
Cost 31 March 2026
86 667
2 114 495
1 623 990
364 578
71 735
4 261 465
Acc. depreciation 1 January 2026
-1 838
0
-108 880
-72 212
-24 957
-207 889
Depreciation for the period
-427
-10 565
-7 063
-2 672
-20 727
Net book value 31 March 2026
84 403
2 114 495
1 504 544
285 302
44 106
4 032 850
Note 5 Finance income and finance cost
Finance income
(in NOK thousand)
Q1 2026
Q1 2025
2025
Interest income
10
3 983
5 916
Change in value of financial derivatives (gain)
7 547
427
0
Foreign exchange gains
906
331
3 811
Other finance income
941
0
19
Financial income
9 403
4 742
9 746
Share of net income from associated companies
-662
-859
-5 477
Total financial income
8 741
3 883
4 269
Finance expenses
(in NOK thousand)
Q1 2026
Q1 2025
2025
Interest on debts and borrowings
38 805
12 469
110 508
Capitalised borrowing costs - general borrowings
-10 029
0
-36 742
Capitalised borrowing costs - specific borrowings
-21 223
0
-44 413
Realized loss/gain on interest derivative
-1 634
-1 509
-6 019
Change in value of financial derivatives (loss)
0
0
3 005
Foreign exchange losses
2 632
432
5 340
Other finance expenses
217
229
914
Total financial expenses
8 767
11 621
32 593
Net financial income/- expenses
-26
-7 738
-28 324
Application of IAS 23 has been taken into consideration where the Group has general borrowings which has partly been financing qualifying assets but not been directly allocated to the construction of a qualifying asset.
The Group did not have any fair value adjustments of financial liabilities in 2026, nor in 2025.
Note 6 Tax
(in NOK thousand)
Q1 2026
Q1 2025
Profit/loss before tax
-38 191
-52 407
Calculated tax (22%)
-8 402
-11 529
Tax payable
0
0
Change in deferred tax (asset)
-8 402
-11 529
Change in deferred tax not recognised in the balance sheet
8 402
11 529
Tax expense
0
0
Income tax expense is recognised based on management’s estimate of the weighted average effective annual income tax rate expected for the full financial year. The estimated average annual tax rate used for the period ended 31 March 2026 is 22%, compared to 22% for the period ended 31 March 2025.
Deferred tax benefit has not been recognised in the balance sheet as the Companies within the group are in their start-up phase and does not have any historical results to refer to when assessing whether future taxable profits will be sufficient to utilize the tax benefit.
Note 7 Earnings per share
(in NOK thousand)
Q1 2026
Q1 2025
Gain/loss attributable to the equity owners of the Group
-38 191
-52 407
Gain/loss for calculation of diluted earnings per share
-38 191
-52 407
Weighted average number of shares outstanding1)
462 603 306
462 603 306
Dilutive options
0
0
Average number om shares and options used in calculation for diluted EPS
462 603 306
462 603 306
Basic earnings per share (NOK)
-0,08
-0,11
Diluted earnings per share (NOK)
-0,08
-0,11
Basic earnings per share are based on the weighted average number of common shares outstanding during the period.
Q1 2026: The Company had 462,603,306 shares for the whole period.
Q1 2025: The Company had 462,603,306 shares for the whole period.
Note 8 Share capital & capital history
(in NOK thousand)
Date
Capital Increase
Share Capital After Change
Par Value
Subscription price per share
New shares
Total no. of outstanding shares
Opening balance 1 July 2020
5 375 159
0,05
107 503 182
Share options exercised
10 July 2020
30 000
5 405 159
0,05
3,33
600 000
108 103 182
Private placement
23 July 2020
581 395
5 986 554
0,05
4,30
11 627 906
119 731 088
Private placement
11 September 2020
5 000 000
10 986 554
0,05
5,00
100 000 000
219 731 088
Private placement
23 March 2021
4 166 667
15 153 221
0,05
6,00
83 333 333
303 064 421
Acquisition Kraft Laks
16 August 2021
109 535
15 262 756
0,05
7,58
2 190 694
305 255 115
Private placement
12 October 2021
277 068
15 539 824
0,05
7,71
5 541 374
310 796 489
Share options exercised
26 March 2022
81 250
15 621 074
0,05
4,80
1 625 000
312 421 489
Private placement
5 April 2022
1 666 667
17 287 741
0,05
9,00
33 333 333
345 754 822
Private placement
18 April 2023
3 409 091
20 696 832
0,05
7,70
68 181 818
413 936 640
Private placement
18 June 2024
2 433 333
23 130 165
0,05
7,50
48 666 666
462 603 306
The Company entered into an investment agreement with Dongwon Industries and completed a NOK 50 million in towards Dongwon Industries in July 2020.
The Company raised NOK 500 million in a private placement in connection with its initial public offering related to the admission on Merkur Market (now Oslo Børs) in September 2020. Further, the Company also raised another NOK 500 million in a private placement in March 2021.
In August 2021 the Company acquired 100% of the shares in Kraft Laks AS. As part of the settlement the Company issued 2,190,694 new shares of NOK 7.6 per share and thereby increased its equity by NOK 16.6 million. In October 2021 the Company carried out a private placement of USD 5m (NOK ~43m) towards Cargill.
Further, in April 2022 the Company carried out a private placement raising gross proceeds of NOK 300 million at a subscription price of NOK 9.0 per share.
In April 2023 the Company carried out a private placement raising gross proceed of NOK 525 million at a subscription price of NOK 7.7 per share.
In June 2024 the Company carried out a private placement raising gross proceed of NOK 365 million at a subscription price of NOK 7.5 per share.
See note 11 subsequent events.
Note 9 Interest bearing debt
Long-term interest bearing dept
(in NOK thousand)
31.03.2026
31.03.2025
Debt to credit institutions
17 300
818 800
Leasing liabilities
29 114
32 019
Total long-term interest-bearing debt
46 414
850 819
Short-term interes bearing dept
(in NOK thousand)
31.03.2026
31.03.2025
Debt to credit institutions
2 187 697
163 237
Leasing liabilitites
10 925
12 819
Total short-term interest-bearing debt
2 198 622
176 056
Total interest-bearing debt
2 245 036
1 026 875
Cash & cash equivalents
137 294
163 438
Net interest-bearing debt
2 107 742
863 437
As per 31 March 2026, 1,797 NOKm was drawn of the existing senior secured debt financing package. In addition, the Company has drawn 199 NOKm, of the 200 NOKm available under the Overdraft Facility.
The Company has also entered into loan agreements for a total of NOK 60 million relating to Salmon Evolution Dale AS of which around NOK 48 million was drawn as per 31 March 2026. This loan is for financing of working capital, investments in Salmon Evolution Dale as well as refinancing of the seller’s credit from the acquisition of Salmon Evolution Dale AS. The above table does not include other long-term liabilities of NOK 3.6 million related to water rights in Salmon Evolution Dale AS.
The loans are floating interest rate loans denominated in NOK with an interest charge based on NIBOR 3M plus an agreed margin.
In April 2026 Salmon Evolution refinanced and expanded its existing senior secured debt financing package related to Indre Harøy Phase 1 and 2, from 2,225 NOKm to 2,475 NOKm, as well as raising gross proceeds of 411.3 NOKm in equity in a private placement.
Financial covenants
The most important financial covenants for the long-term financing of the Company are, respectively, a solvency requirement that the borrower’s (Salmon Evolution Norway AS) book equity ratio (including intra-group loans) shall be minimum 45% (updated agreement: 37.5 %). Further, there is a profitability requirement linked to the borrower’s EBITDA which shall be greater than NOK 250 million on a last 12-month basis from Q2 2027 (updated agreement: NOK 200 million). The minimum EBITDA levels reflects the Company’s gradual ramp up of production volumes and profitability in phases 1 and 2
Finally, there is a minimum cash requirement that stipulates that the obligors (Salmon Evolution Norway AS, Salmon Evolution Sales AS and Salmon Evolution ASA) cash balance shall be greater than NOK 100 million at any time (updated agreement: no change). Any undrawn and available amounts under the revolving facility and the overdraft is included in the calculation of the cash balance. Additionally there is included a solvency requirement from Q3 2028 in the updated agreement.
Security
The Company’s bank debt facilities are fully guaranteed by Salmon Evolution ASA. The respective lenders also have a pledge over 100% of the shares in the borrower, Salmon Evolution Norway AS and Salmon Evolution Dale AS. Furthermore, the respective lenders have a pledge over all material operating assets of the Company, hereunder inter alia, land, plant and machinery, operating licenses, inventory and receivables.
Cash movements in financial activities
(NOK thousand)
Short term
Long term
Balance at January 1, 2025
163 805
582 411
Repayment of loans and borrowings
-45 120
-300
Proceeds from new bank loan
49 870
250 000
Change in leases liabilities
7 502
22 351
Balance at March 31, 2025
176 056
854 462
Balance at January 1, 2026
345 558
1 578 959
Repayment of loans and borrowings
-696
-300
Proceeds from new bank loan
1 853 822
-1 527 628
Change in leases liabilities
-61
-974
Balance at March 31, 2026
2 198 623
50 057
Note 10 Transactions with related parties
During the ordinary course of business, the Company may engage in certain arm’s length transactions with related parties.
There were no material transactions with related parties in 2025.
Note 11 Subsequent events
Solid capital structure in place following completion of refinancing and private placement in April - existing long-term debt facilities linked to Indre Harøy increased by 250 NOKm from 2,225 to 2,475 NOKm and private placement raising gross proceeds of 411,3 NOKm.
ABOUT SALMON EVOLUTION
Salmon Evolution is the global leader within land-based salmon farming. Pioneering the hybrid flow-through system (HFS), Salmon Evolution is Extending the Ocean Potential by creating optimal growth conditions in a controlled environment on land. This approach, capturing the benefits of both land-based and sea-based farming, puts biology first and limits operational and biological risk.
Salmon Evolution is strategically located the heart of the global aquaculture industry on the west coast of Norway, where the Company has its first facility and global centre of excellence fully operational at industrial scale. Enabled by proof of concept in at Indre Harøy, Salmon Evolution targets significant expansion.
Salmon Evolution is listed on Oslo Børs under the ticker SALME. To learn more, please visit www.salmonevolution.no.